#brazil paralysis treatment approval

ANVISA Approves Polylaminin: Brazil's Breakthrough Treatment for Spinal Cord Injury

ANVISA granted landmark approval for polylaminin-based therapy for spinal cord injury in April 2026, offering the first disease-modifying treatment for paralysis patients in Brazil and a potential glo